Concepedia

Author

Thierry Façon

Hôpital Claude HuriezORCID

Also Known As

Facon Thierry, Facon, T., Facon, Thierry, Guang Chen, Ismail Elalamy, Sandrine Combret, T FACON, T Facon, T Façon, T. Facon

953

Publications

61.1K

Citations

113

H-Index

156

Concepts

All Affiliations

Hôpital Claude HuriezCentre Hospitalier Universitaire de LilleCentre Hospitalier Universitaire de NantesInsermDana-Farber Cancer Institute
TF

About

Thierry Façon is an author at Hôpital Claude Huriez specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

54

138

16.3K

2

Health Sciences

41

90

11.2K

3

Public Health

5

5

121

4

Education

1

1

15

5

Engineering

1

1

27

Thierry Façon

×

365

Publications

53.9K

Citations

103

H-Index

YearCitations

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

Michel Attal, Jean‐François Rossi, Philippe Casassus,

New England Journal of Medicine

1996

2.6K

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster,

New England Journal of Medicine

2005

2.5K

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva,

Journal of Clinical Oncology

2015

2.1K

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Meletios Α. Dimopoulos, Andrew Spencer, Michael Attal,

New England Journal of Medicine

2007

1.4K

Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma

Michel Attal, Valérie Lauwers‐Cancès, Cyrille Hulin,

New England Journal of Medicine

2017

1.2K

Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit,

New England Journal of Medicine

2012

1.1K

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

S. Vincent Rajkumar, Jean‐Luc Harousseau, Brian G.M. Durie,

Blood

2011

1K

Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

Michel Attal, Thierry Façon, François Guilhot,

New England Journal of Medicine

2003

973

Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

Thierry Façon, Shaji Kumar, Torben Plesner,

New England Journal of Medicine

2019

947

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau, Michel Attal, Cyrille Hulin,

The Lancet

2019

922

Page 1